News & Updates

Use of saffron (Crocus Sativus) as an alternative or supplemental treatment for ulcerative colitis (UC) leads to improvements in clinical response for faecal calprotectin and in partial Mayo scores, according to a study presented at the recently concluded 2022 Crohn’s & Colitis Congress.

Autologous breast reconstruction achieves comparable operative time and rate of surgical procedures as implant-based reconstructions, a recent study has found. However, medium-term costs are much higher for autologous operations.

Use of selective serotonin reuptake inhibitors (SSRIs) poses no risk of noncardioembolic ischaemic stroke and is even protective when compared with other antidepressants, according to a recent study.

The presence of appendicolith is tied to an almost twofold risk of requiring an appendectomy within 30 days in patients who initially received antibiotic therapy for acute uncomplicated appendicitis, according to an analysis of the CODA* study from the US.

Compared with warfarin, rivaroxaban lowers the risk and rate of renal decline in patients with nonvalvular atrial fibrillation (NVAF), a new study reports.

Using the probiotic Escherichia coli Nissle 1917 (EcN) as add-on therapy for patients with mild-to-moderate ulcerative colitis (UC) helps induce disease remission and preserve quality of life (QoL) in these patients, according to studies presented at CCC 2022.